Our top pick for
Mechel PAO is a steel business based in the US. Mechel PAO shares (MTL) are listed on the NYSE and all prices are listed in US Dollars.
|Latest market close||$4.49|
|52-week range||$1.29 - $4.74|
|50-day moving average||$4.04|
|200-day moving average||$2.57|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.54|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||9.25%|
|1 month (2021-09-17)||16.32%|
|3 months (2021-07-16)||112.80%|
|6 months (2021-04-16)||131.44%|
|1 year (2020-10-16)||213.99%|
|2 years (2019-10-17)||141.40%|
|3 years (2018-10-17)||44.37%|
|5 years (2016-10-17)||52.72%|
Valuing Mechel PAO stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mechel PAO's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mechel PAO's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Mechel PAO shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Mechel PAO's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $71.1 billion.
The EBITDA is a measure of a Mechel PAO's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$318.6 billion|
|Operating margin TTM||18.85%|
|Gross profit TTM||$94.8 billion|
|Return on assets TTM||18.51%|
|Return on equity TTM||-9999999%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
There are currently 490,279 Mechel PAO shares held short by investors – that's known as Mechel PAO's "short interest". This figure is 71.2% up from 286,403 last month.
There are a few different ways that this level of interest in shorting Mechel PAO shares can be evaluated.
Mechel PAO's "short interest ratio" (SIR) is the quantity of Mechel PAO shares currently shorted divided by the average quantity of Mechel PAO shares traded daily (recently around 1.3 million). Mechel PAO's SIR currently stands at 0.37. In other words for every 100,000 Mechel PAO shares traded daily on the market, roughly 370 shares are currently held short.
However Mechel PAO's short interest can also be evaluated against the total number of Mechel PAO shares, or, against the total number of tradable Mechel PAO shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Mechel PAO's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Mechel PAO shares in existence, roughly 0 shares are currently held short) or 0.0032% of the tradable shares (for every 100,000 tradable Mechel PAO shares, roughly 3 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Mechel PAO.
Find out more about how you can short Mechel PAO stock.
We're not expecting Mechel PAO to pay a dividend over the next 12 months.
Mechel PAO's shares were split on a 1:2 basis on 11 January 2016. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Mechel PAO shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Mechel PAO shares which in turn could have impacted Mechel PAO's share price.
Over the last 12 months, Mechel PAO's shares have ranged in value from as little as $1.29 up to $4.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Mechel PAO's is 1.4312. This would suggest that Mechel PAO's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Mechel PAO, together with its subsidiaries, engages in mining, steel, and power businesses in Russia, Asia, Europe, the Commonwealth of Independent States, the Middle East, the United States, and internationally. Its Mining segment produces and sells coking, metallurgical, and steam coal; coke; chemical products, including coal tar, coal benzene, and other compounds; and iron ore and iron ore concentrates. The company's Steel segment produces and sells semi-finished steel products, long steel products, and carbon and stainless flat products; ferrosilicon products; and pig iron, as well as metal products, including wire products, stampings and forgings, structural shapes, beams, and rails. Its Power segment generates and supplies electricity, heat energy, and other power resources to third parties. Mechel PAO also offers sea, rail, and motor transportation logistics services to third parties. The company was formerly known as Mechel OAO and changed its name to Mechel PAO in March 2016. Mechel PAO was incorporated in 2003 and is based in Moscow, Russia.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.